NovoCure Ltd
NVCR- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001645113
No open-market purchases or sales by NovoCure Ltd insiders were filed in the last 90 days; 218 institutions reported holding it in 13F filings for Q2 2026, worth $1.57B in total; no superinvestor holds it.
Superinvestors holding NVCR, Q2 2026
No superinvestor reported holding NVCR in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of NVCR each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- Coatue Management
Q1 2024
1 superinvestor holding at quarter end
- Added
- Coatue Management (+74.8%)
Q4 2023
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−60.7%)
Q2 2023
1 superinvestor holding at quarter end
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2021
1 superinvestor holding at quarter end